• Citer

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

par Leal, Ticiana;Kotecha, Rupesh;Ramlau, Rodryg;Milanowski, Janusz;Cobo, Manuel;Roubec, Jaromir;Petruzelka, L;Havel, Libor;Kalmadi, Jujith;Ward, Jeffrey;Andrić, Zoran;Berghmans, Thierry ;Gerber, David, E;Kloecker, Goetz;Panikkar, Rajiv;Aerts, Joachim J.G.J.V.;Delmonte, Angelo;Pless, Miklos;Greil, Richard;Rolfo, Christian;A Beccara, Wallace;Eaton, Michael;Iqbal, Mussawar;Langer, Corey
Référence Lancet oncology, 24, page (1002-1017)
Publication A Paraître, 2023-09-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques